These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor. Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217 [TBL] [Abstract][Full Text] [Related]
4. Sesquiterpene Lactones with Dual Inhibitory Activity against the Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381 [TBL] [Abstract][Full Text] [Related]
5. In Silico and In Vitro Search for Dual Inhibitors of the Possart K; Herrmann FC; Jose J; Schmidt TJ Molecules; 2023 Nov; 28(22):. PubMed ID: 38005256 [TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors. Dube D; Periwal V; Kumar M; Sharma S; Singh TP; Kaur P J Mol Model; 2012 May; 18(5):1701-11. PubMed ID: 21826447 [TBL] [Abstract][Full Text] [Related]
7. Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Tassone G; Landi G; Linciano P; Francesconi V; Tonelli M; Tagliazucchi L; Costi MP; Mangani S; Pozzi C Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209148 [No Abstract] [Full Text] [Related]
8. Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major. Omolabi KF; Iwuchukwu EA; Odeniran PO; Soliman MES Comput Biol Chem; 2021 Feb; 90():107412. PubMed ID: 33199197 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790 [TBL] [Abstract][Full Text] [Related]
10. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886 [TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Development of Cycloguanil Derivatives as Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections. Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048 [TBL] [Abstract][Full Text] [Related]
14. Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign. Linciano P; Cullia G; Borsari C; Santucci M; Ferrari S; Witt G; Gul S; Kuzikov M; Ellinger B; Santarém N; Cordeiro da Silva A; Conti P; Bolognesi ML; Roberti M; Prati F; Bartoccini F; Retini M; Piersanti G; Cavalli A; Goldoni L; Bertozzi SM; Bertozzi F; Brambilla E; Rizzo V; Piomelli D; Pinto A; Bandiera T; Costi MP Eur J Med Chem; 2020 Mar; 189():112047. PubMed ID: 31982652 [TBL] [Abstract][Full Text] [Related]
15. Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Linciano P; Dawson A; Pöhner I; Costa DM; Sá MS; Cordeiro-da-Silva A; Luciani R; Gul S; Witt G; Ellinger B; Kuzikov M; Gribbon P; Reinshagen J; Wolf M; Behrens B; Hannaert V; Michels PAM; Nerini E; Pozzi C; di Pisa F; Landi G; Santarem N; Ferrari S; Saxena P; Lazzari S; Cannazza G; Freitas-Junior LH; Moraes CB; Pascoalino BS; Alcântara LM; Bertolacini CP; Fontana V; Wittig U; Müller W; Wade RC; Hunter WN; Mangani S; Costantino L; Costi MP ACS Omega; 2017 Sep; 2(9):5666-5683. PubMed ID: 28983525 [TBL] [Abstract][Full Text] [Related]
16. Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti- Francesconi V; Rizzo M; Pozzi C; Tagliazucchi L; Konchie Simo CU; Saporito G; Landi G; Mangani S; Carbone A; Schenone S; Santarém N; Tavares J; Cordeiro-da-Silva A; Costi MP; Tonelli M ACS Infect Dis; 2024 Jul; ():. PubMed ID: 38953453 [TBL] [Abstract][Full Text] [Related]
17. In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants. Setzer WN; Ogungbe IV PLoS Negl Trop Dis; 2012; 6(7):e1727. PubMed ID: 22848767 [TBL] [Abstract][Full Text] [Related]
18. Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis. Zhao Y; Wang Q; Meng Q; Ding D; Yang H; Gao G; Li D; Zhu W; Zhou H Bioorg Med Chem; 2012 Feb; 20(3):1240-50. PubMed ID: 22249121 [TBL] [Abstract][Full Text] [Related]
19. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target. Rashmi M; Swati D Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach. Parenti MD; Pacchioni S; Ferrari AM; Rastelli G J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]